Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory S Day

Showing results (51-60 of 275) with videos related to

Pageof 28
Sort By:
Iscience|September 22, 2018
Suspension Processing of Microporous Metal-Organic Frameworks: A Scalable Route to High-Quality AdsorbentsAngelo Kirchon, Gregory S Day, Yu Fang, et al.
Journal of Alzheimer'S Disease : JAD|January 25, 2021
Clinical and Paraclinical Measures Associated with Outcome in Cerebral Amyloid Angiopathy with Related InflammationAlan S Plotzker, Rachel L Henson, Anne M Fagan, et al.
JAMA Network Open|October 17, 2019
Association of Acquired and Heritable Factors With Intergenerational Differences in Age at Symptomatic Onset of Alzheimer Disease Between Offspring and Parents With DementiaGregory S Day, Carlos Cruchaga, Thomas Wingo, et al.
Journal of Neurology|March 31, 2016
N-methyl-D-aspartate receptor encephalitis mediates loss of intrinsic activity measured by functional MRIMatthew R Brier, Gregory S Day, Abraham Z Snyder, et al.
Neuropathology and Applied Neurobiology|March 11, 2014
LGI1 autoantibodies associated with cerebellar degenerationClaude Steriade, Gregory S Day, Liesly Lee, et al.
Research Square|February 16, 2022
Neurocognitive Screening in Patients Following SARS-CoV-2 Infection: Tools for TriageKaren Blackmon, Gregory S Day, Harry Ross Powers, et al.
Handbook of Clinical Neurology|April 30, 2013
Anti-NMDA receptor encephalitis in children: the disorder, its diagnosis, and treatmentHarry E Peery, Gregory S Day, Asif Doja, et al.
BMC Neurology|July 30, 2022
Neurocognitive screening in patients following SARS-CoV-2 infection: tools for triageKaren Blackmon, Gregory S Day, Harry Ross Powers, et al.
Alzheimer Disease and Associated Disorders|May 7, 2019
Patient Stakeholder Versus Physician Preferences Regarding Amyloid PET TestingMelissa J Armstrong, Gary S Gronseth, Gregory S Day, et al.
Trends in Molecular Medicine|October 8, 2025
Anti-N-methyl-d-aspartate receptor encephalitis: insights and future treatment directionsYoji Hoshina, Tammy L Smith, Melissa A Wright, et al.
Pageof 28

Showing results (51-60 of 275) with videos related to

Sort By:
Pageof 28
Iscience|September 22, 2018
Suspension Processing of Microporous Metal-Organic Frameworks: A Scalable Route to High-Quality AdsorbentsAngelo Kirchon, Gregory S Day, Yu Fang, et al.
Journal of Alzheimer'S Disease : JAD|January 25, 2021
Clinical and Paraclinical Measures Associated with Outcome in Cerebral Amyloid Angiopathy with Related InflammationAlan S Plotzker, Rachel L Henson, Anne M Fagan, et al.
JAMA Network Open|October 17, 2019
Association of Acquired and Heritable Factors With Intergenerational Differences in Age at Symptomatic Onset of Alzheimer Disease Between Offspring and Parents With DementiaGregory S Day, Carlos Cruchaga, Thomas Wingo, et al.
Journal of Neurology|March 31, 2016
N-methyl-D-aspartate receptor encephalitis mediates loss of intrinsic activity measured by functional MRIMatthew R Brier, Gregory S Day, Abraham Z Snyder, et al.
Neuropathology and Applied Neurobiology|March 11, 2014
LGI1 autoantibodies associated with cerebellar degenerationClaude Steriade, Gregory S Day, Liesly Lee, et al.
Research Square|February 16, 2022
Neurocognitive Screening in Patients Following SARS-CoV-2 Infection: Tools for TriageKaren Blackmon, Gregory S Day, Harry Ross Powers, et al.
Handbook of Clinical Neurology|April 30, 2013
Anti-NMDA receptor encephalitis in children: the disorder, its diagnosis, and treatmentHarry E Peery, Gregory S Day, Asif Doja, et al.
BMC Neurology|July 30, 2022
Neurocognitive screening in patients following SARS-CoV-2 infection: tools for triageKaren Blackmon, Gregory S Day, Harry Ross Powers, et al.
Alzheimer Disease and Associated Disorders|May 7, 2019
Patient Stakeholder Versus Physician Preferences Regarding Amyloid PET TestingMelissa J Armstrong, Gary S Gronseth, Gregory S Day, et al.
Trends in Molecular Medicine|October 8, 2025
Anti-N-methyl-d-aspartate receptor encephalitis: insights and future treatment directionsYoji Hoshina, Tammy L Smith, Melissa A Wright, et al.
Pageof 28